Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Integrated Circuit Industry Investment Fund, commonly known as the "Big Fund," is a state-backed investment vehicle established by the Chinese government to foster the growth and self-sufficiency of the domestic semiconductor industry. Launched in 2014, the fund operates through multiple investment phases, raising hundreds of billions of yuan from the Ministry of Finance and other state-owned enterprises. Its investment strategy covers the entire integrated circuit (IC) value chain, including chip design, manufacturing, packaging, testing, and equipment materials. While the fund is not a healthcare or life sciences company, its investments in high-performance computing and sensor technology support the development of advanced medical devices and diagnostic infrastructure. The fund is managed by Sino-IC Capital and plays a central role in China's strategic industrial policy to achieve technological self-reliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National IC Industry Investment Fund.